Montreal-based Tactio Health Group will run a 25-person pilot study with the University of Michigan Health System to test its technology that works with smartphone-connected remote patient monitoring devices. In the study, researchers will be looking at the effects of pharmacist-led home blood pressure monitoring and medication reminders on people with hypertension.

“This study seeks to put patient collected data into the hands of a healthcare provider who has the ability to act on that data in near-real time,” said Lorraine Buis, assistant professor in the University’s Department of Family Medicine, who will lead the study. “By using the TactioRPM platform to connect patients with their providers, and by better understanding how to meaningfully integrate this technology into a clinical setting, we have the potential to demonstrate the full benefit that mobile health has to offer.”

Study participants will be given Bluetooth-connected blood pressure monitors and Tactio’s TactioRPM mobile app so they could beam their vitals data to clinical pharmacists. The pharmacists on their end will be able to intervene as needed, based on the patients’ readings and adherence.

The recruitment will begin immediately and the study is set to conclude in the first half of 2016.

The recruitment will begin immediately and the study is set to conclude in the first half of 2016.Tactio’s software connects to biometric data collection devices such as activity trackers, body scales, heart rate monitors, glucometers, oximeters, thermometers, and blood pressure monitors. The company offers its solution to hospitals, pharmacies, researchers, and even insurance plans.

Tactio Health has recently complited a pilot of its technology at a Quebec assisted living facility, where it was successful enough for the center to continue with the offering after the pilot’s completion.

[Via: mobihealthnews]